Madrigal Pharmaceuticals, Inc. (MDGL) on GreekSoup https://greeksoup.ai/stocks/us/mdgl/ Every dated entry in the public record on Madrigal Pharmaceuticals, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Wed, 28 Oct 2026 00:00:00 +0000 Madrigal Pharmaceuticals, Inc.: short interest 2,194,545 shares at the 15 October 2026 settlement, 7.24 days to coverhttps://greeksoup.ai/stocks/us/mdgl/short-interest/us:MDGL:short-interest:2026-10-15:e9ed07aeb1Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: short interest 2,396,369 shares at the 30 September 2026 settlement, 9.78 days to coverhttps://greeksoup.ai/stocks/us/mdgl/short-interest/us:MDGL:short-interest:2026-09-30:dea7f12e1eWed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: Form 144, PAUL FRIEDMAN plans to sell 50,000 shares worth $25.8 million around 28 September 2026https://greeksoup.ai/stocks/us/mdgl/planned-sales/us:MDGL:planned-sale:2026-09-28:7f2526309fMon, 28 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: short interest 2,254,423 shares at the 15 September 2026 settlement, 11.42 days to coverhttps://greeksoup.ai/stocks/us/mdgl/short-interest/us:MDGL:short-interest:2026-09-15:a3631b1052Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: Form 144, WILLIAM SIBOLD plans to sell 5,221 shares worth $2.8 million around 11 September 2026https://greeksoup.ai/stocks/us/mdgl/planned-sales/us:MDGL:planned-sale:2026-09-11:938e66a262Fri, 11 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: Sibold William John (President and CEO) sold 60 shares (under a trading plan set in advance) at $533.09 on 11 September 2026, $31,985https://greeksoup.ai/stocks/us/mdgl/insiders/us:MDGL:insider:2026-09-11:a8c1dc382dFri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: Sibold William John (President and CEO) sold 106 shares (under a trading plan set in advance) at $534.06 on 11 September 2026, $56,611https://greeksoup.ai/stocks/us/mdgl/insiders/us:MDGL:insider:2026-09-11:813a510809Fri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: Sibold William John (President and CEO) sold 218 shares (under a trading plan set in advance) at $535.94 on 11 September 2026, $116,836https://greeksoup.ai/stocks/us/mdgl/insiders/us:MDGL:insider:2026-09-11:13bb9b1edeFri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: Sibold William John (President and CEO) sold 160 shares (under a trading plan set in advance) at $537.62 on 11 September 2026, $86,019https://greeksoup.ai/stocks/us/mdgl/insiders/us:MDGL:insider:2026-09-11:777b16600dFri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: Sibold William John (President and CEO) sold 687 shares (under a trading plan set in advance) at $540.59 on 11 September 2026, $371,382https://greeksoup.ai/stocks/us/mdgl/insiders/us:MDGL:insider:2026-09-11:7ac8bb8152Fri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: Sibold William John (President and CEO) sold 368 shares (under a trading plan set in advance) at $541.64 on 11 September 2026, $199,324https://greeksoup.ai/stocks/us/mdgl/insiders/us:MDGL:insider:2026-09-11:f45d05f38aFri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: Sibold William John (President and CEO) sold 1,202 shares (under a trading plan set in advance) at $542.60 on 11 September 2026, $652,209https://greeksoup.ai/stocks/us/mdgl/insiders/us:MDGL:insider:2026-09-11:21bebc8d9fFri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: Sibold William John (President and CEO) sold 1,539 shares (under a trading plan set in advance) at $544.02 on 11 September 2026, $837,253https://greeksoup.ai/stocks/us/mdgl/insiders/us:MDGL:insider:2026-09-11:8f30e5a0b9Fri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: Sibold William John (President and CEO) sold 761 shares (under a trading plan set in advance) at $544.83 on 11 September 2026, $414,616https://greeksoup.ai/stocks/us/mdgl/insiders/us:MDGL:insider:2026-09-11:18fbae517eFri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: Sibold William John (President and CEO) sold 120 shares (under a trading plan set in advance) at $546.38 on 11 September 2026, $65,565https://greeksoup.ai/stocks/us/mdgl/insiders/us:MDGL:insider:2026-09-11:5876d40ecaFri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: Sibold William John (President and CEO) sold 131 shares (under a trading plan set in advance) at $527.88 on 9 September 2026, $69,152https://greeksoup.ai/stocks/us/mdgl/insiders/us:MDGL:insider:2026-09-11:98ee3971ffFri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: Sibold William John (President and CEO) sold 347 shares (under a trading plan set in advance) at $529.27 on 9 September 2026, $183,656https://greeksoup.ai/stocks/us/mdgl/insiders/us:MDGL:insider:2026-09-11:6f911c7c1fFri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: Sibold William John (President and CEO) sold 522 shares (under a trading plan set in advance) at $530.23 on 9 September 2026, $276,781https://greeksoup.ai/stocks/us/mdgl/insiders/us:MDGL:insider:2026-09-11:0eed225b02Fri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: Sibold William John (President and CEO) sold 368 shares (under a trading plan set in advance) at $531.99 on 9 September 2026, $195,772https://greeksoup.ai/stocks/us/mdgl/insiders/us:MDGL:insider:2026-09-11:5bc2a4ebf2Fri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: Sibold William John (President and CEO) sold 512 shares (under a trading plan set in advance) at $533.09 on 9 September 2026, $272,944https://greeksoup.ai/stocks/us/mdgl/insiders/us:MDGL:insider:2026-09-11:2840bee0d8Fri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: Sibold William John (President and CEO) sold 396 shares (under a trading plan set in advance) at $534.20 on 9 September 2026, $211,542https://greeksoup.ai/stocks/us/mdgl/insiders/us:MDGL:insider:2026-09-11:5757e17fe9Fri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: Sibold William John (President and CEO) sold 644 shares (under a trading plan set in advance) at $535.27 on 9 September 2026, $344,715https://greeksoup.ai/stocks/us/mdgl/insiders/us:MDGL:insider:2026-09-11:efaa23b00eFri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: Sibold William John (President and CEO) sold 1,040 shares (under a trading plan set in advance) at $536.11 on 9 September 2026, $557,557https://greeksoup.ai/stocks/us/mdgl/insiders/us:MDGL:insider:2026-09-11:97052447e2Fri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: Sibold William John (President and CEO) sold 640 shares (under a trading plan set in advance) at $537.17 on 9 September 2026, $343,791https://greeksoup.ai/stocks/us/mdgl/insiders/us:MDGL:insider:2026-09-11:b7993856d9Fri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: Sibold William John (President and CEO) sold 520 shares (under a trading plan set in advance) at $538.30 on 9 September 2026, $279,914https://greeksoup.ai/stocks/us/mdgl/insiders/us:MDGL:insider:2026-09-11:e616be167bFri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: Sibold William John (President and CEO) sold 215 shares (under a trading plan set in advance) at $539.03 on 9 September 2026, $115,891https://greeksoup.ai/stocks/us/mdgl/insiders/us:MDGL:insider:2026-09-11:3185163c38Fri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: Sibold William John (President and CEO) sold 505 shares (under a trading plan set in advance) at $540.19 on 9 September 2026, $272,796https://greeksoup.ai/stocks/us/mdgl/insiders/us:MDGL:insider:2026-09-11:ac145bab38Fri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: Sibold William John (President and CEO) sold 362 shares (under a trading plan set in advance) at $541.65 on 9 September 2026, $196,079https://greeksoup.ai/stocks/us/mdgl/insiders/us:MDGL:insider:2026-09-11:3a3d0c5f64Fri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: Sibold William John (President and CEO) sold 160 shares (under a trading plan set in advance) at $542.55 on 9 September 2026, $86,808https://greeksoup.ai/stocks/us/mdgl/insiders/us:MDGL:insider:2026-09-11:17c3e01ef3Fri, 11 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: Form 144, William John Sibold plans to sell 6,362 shares worth $3.4 million around 9 September 2026https://greeksoup.ai/stocks/us/mdgl/planned-sales/us:MDGL:planned-sale:2026-09-09:36b297a7e0Wed, 09 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: short interest 2,240,575 shares at the 31 August 2026 settlement, 9.46 days to coverhttps://greeksoup.ai/stocks/us/mdgl/short-interest/us:MDGL:short-interest:2026-08-31:7329191628Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: Form 144, Shannon Kelley plans to sell 664 shares worth $337,020 around 17 August 2026https://greeksoup.ai/stocks/us/mdgl/planned-sales/us:MDGL:planned-sale:2026-08-20:c7cab3fb54Thu, 20 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: Kelley Shannon T (General Counsel) sold 664 shares at $514.97 on 17 August 2026, $341,940https://greeksoup.ai/stocks/us/mdgl/insiders/us:MDGL:insider:2026-08-20:f86e43cf5cThu, 20 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: short interest 2,025,404 shares at the 14 August 2026 settlement, 6.05 days to coverhttps://greeksoup.ai/stocks/us/mdgl/short-interest/us:MDGL:short-interest:2026-08-14:c58fc9ae2bFri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc. filed 8-K: officer or director change, regulation fd disclosurehttps://greeksoup.ai/stocks/us/mdgl/filings/us:MDGL:filing:2026-08-12:ed2b09a714Wed, 12 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc.: short interest 1,965,849 shares at the 31 July 2026 settlement, 4.84 days to coverhttps://greeksoup.ai/stocks/us/mdgl/short-interest/us:MDGL:short-interest:2026-07-31:3792272637Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc. Q2 FY2026 results: revenue $364 million, net income -$58 millionhttps://greeksoup.ai/stocks/us/mdgl/results/fy2026-q2/us:MDGL:result:2026-07-30:d51f7ec211Thu, 30 Jul 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/mdgl/filings/us:MDGL:filing:2026-07-30:05f97dcd7aThu, 30 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Madrigal Pharmaceuticals, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/mdgl/filings/us:MDGL:filing:2026-07-30:f5ee0bfa6fThu, 30 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]>